Filters
The UPC going beyond its borders: how your company can profit from the latest case law
The UPC now allows life sciences companies to enforce European patents more efficiently across multiple countries through its long-arm jurisdiction. This lets patent holders sue distributors based in UPC member states in a single action, even if products are sold or made in non-UPC countries. Following key rulings the UPC can issue cross-border injunctions covering several national patent parts, while respecting jurisdiction limits on patent validity challenges.
5 of 5 Insights
Are offshore wind converter platforms a bottleneck in the energy transition? New German government wants to create production capacities at German shipyards
Taylor Wessing advises Cherry Ventures, Balderton Capital and Leitmotif on €130 million Series A financing round for fusion energy start-up Proxima Fusion
Taylor Wessing advises HOWOGE Wohnungsbaugesellschaft mbH on €200 million tap issue of social notes
Article 48 GDPR – New EDPB Guidelines Clarify How to Handle Data Requests from Third Countries
.png?as=0&dmc=0&iar=0&thn=0&udi=0?as=0&h=182&iar=0&w=375&crop=1&hash=F2775BF2B93112F0E41CD43C8554BD3C)
What have we learned from two years UPC preliminary injunctions?
.png?as=0&dmc=0&iar=0&thn=0&udi=0?as=0&h=182&iar=0&w=375&crop=1&hash=4B3F53F941F2EF34C028C1C2ED7F1793)
UPC and jurisdictional boundaries
China’s Rare Earth Export Controls: Implications for European Defence Companies
Taylor Wessing advises the shareholders of Peter Park System GmbH on growth investment by Great Hill Partners
